Vivalyx

Vivalyx is a biotech company developing a preservation liquid, Vivalyx Omnisol, for optimal organ preservation before transplant. Their patented solution aims to make body-temperature perfusion scalable, improving organ viability and reducing transplantation risks. Vivalyx Omnisol is designed for all perfusion methods and static cold storage, offering significant cost reductions compared to blood-based alternatives.


Buy Funded Startups lists

Funding Round: Seed

Funding Amount: €5.4M

Date: 30-Apr-2024

Investors: TVF

Markets: Biotech, Healthtech

HQ: Aachen, Nordrhein-Westfalen, Germany

Founded: 2022

Website: https://vivalyx.com/

LinkedIn: https://www.linkedin.com/company/vivalyx

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/vivalyx

Pitchbook: https://pitchbook.com/profiles/company/523299-97


Leave a Comment